Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb (SCHUMANN)
A Randomized, Double-blind, Open for Active Comparator, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Three Different Doses of P2X3 Antagonist (BAY1817080) Versus Placebo and Elagolix 150 mg in Women With Symptomatic Endometriosis
Sponsor: Bayer
Terminated
Study terminated by Sponsor
This PHASE2 trial investigates Endometriosis and is currently terminated or withdrawn. Bayer leads this study, which shows 22 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
22 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE2
-
Sep 2025 — Feb 2026 [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE2
▶ Show 17 earlier versions
-
Jul 2023 — Sep 2023 [monthly]
Terminated PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Jul 2022 — Jun 2023 [monthly]
Completed PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — May 2022 [monthly]
Recruiting PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Feb 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Sep 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albuquerque, United States , Athens, Greece , Atlanta, United States , Augusta, United States , Barcelona, Spain , Beavercreek, United States , Beijing, China , Berlin, Germany , Bernburg, Germany , Bialystok, Poland and 107 more locations